Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valdecoxib dose-ranging study in knee osteoarthritis
NCT00650624Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of valdecoxib in osteoarthritis (OA) (4 arms), sponsored by Pfizer. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Pain Index at 6 weeks. Started Jun 2003; status: completed.
02
Drugs
valdecoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00650624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650624.